切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2018, Vol. 07 ›› Issue (03) : 216 -220. doi: 10.3877/cma.j.issn.2095-3232.2018.03.012

所属专题: 文献

临床研究

原发性肝脏神经内分泌肿瘤诊治经验
魏荣光1, 周舟1, 吴浩然1, 程发辉1, 段小辉1, 杨建辉1, 田秉璋1, 周力学1, 毛先海1,()   
  1. 1. 410005 长沙,湖南省人民医院 湖南师范大学第一附属医院肝胆外科
  • 收稿日期:2018-03-18 出版日期:2018-06-10
  • 通信作者: 毛先海
  • 基金资助:
    湖南省教育厅重点项目(16A127); 湖南省卫生计生委科研计划项目(C2015-41)

Diagnosis and treatment experience of primary hepatic neuroendocrine neoplasm

Rongguang Wei1, Zhou Zhou1, Haoran Wu1, Fahui Cheng1, Xiaohui Duan1, Jianhui Yang1, Bingzhang Tian1, Lixue Zhou1, Xianhai Mao1,()   

  1. 1. Department of Hepatobiliary Surgery, Hunan People's Hospital, the First Affiliated Hospital of Hunan Normal University, Changsha 410005, China
  • Received:2018-03-18 Published:2018-06-10
  • Corresponding author: Xianhai Mao
  • About author:
    Corresponding author: Mao Xianhai, Email:
引用本文:

魏荣光, 周舟, 吴浩然, 程发辉, 段小辉, 杨建辉, 田秉璋, 周力学, 毛先海. 原发性肝脏神经内分泌肿瘤诊治经验[J/OL]. 中华肝脏外科手术学电子杂志, 2018, 07(03): 216-220.

Rongguang Wei, Zhou Zhou, Haoran Wu, Fahui Cheng, Xiaohui Duan, Jianhui Yang, Bingzhang Tian, Lixue Zhou, Xianhai Mao. Diagnosis and treatment experience of primary hepatic neuroendocrine neoplasm[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2018, 07(03): 216-220.

目的

探讨原发性肝脏神经内分泌肿瘤(NEN)的诊治及疗效。

方法

回顾性分析2013年3月至2015年12月湖南省人民医院收治的10例原发性肝脏NEN患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男3例,女7例;年龄21~65岁,中位年龄45岁。根据2010版消化系统肿瘤WHO分类标准,神经内分泌瘤(NET)G2 6例,神经内分泌癌(NEC)4例。分析患者临床资料、影像学特点、治疗情况、肿瘤病理学特点及预后。

结果

患者右上腹痛5例,右上腹包块1例,乏力、纳差1例,其余3例患者由常规体检发现。8例影像学诊断为肝孤立性肿块,肝内多发占位2例。10例患者均经病理学检查诊断,其中3例术前活检确诊,7例术后病理学检查确诊。根治性切除6例,微波消融术1例,肝脏肿块切除及静脉化疗泵植入术1例,单纯行化疗1例,放弃治疗1例。截止至投稿日期无复发生存6例;1例术后1个月复发并腹膜后多发淋巴结转移,仍存活;死亡2例,其中1例穿刺活检后放弃治疗死亡,1例化疗1周期后死于肿瘤多发远处转移;失访1例。

结论

肝脏NEN无特异性临床表现,需病理学检查确诊,手术切除为首选治疗方法,对于肿块不可切除的患者可选择TACE、微波消融、化疗等方法。

Objective

To investigate the diagnosis, treatments for primary hepatic neuroendocrine neoplasm (NEN) and the efficacy.

Methods

Clinical data of 10 patients with primary hepatic NEN admitted in Hunan People's Hospital from March 2013 to December 2015 were analyzed retrospectively. The informed consents of all patients were obtained and the local ethical committee approval was received. There were 3 males and 7 females, aged 21-65 years old and the median age was 45 years old. According to the WHO classification for digestive system tumor 2010 version, there were 6 cases of neuroendocrine tumor (NET) G2, and 4 cases of neuroendocrine carcinoma (NEC). The clinical data, imaging characteristics, treatment, tumor pathological characteristics and prognosis of the patients were analyzed.

Results

Right upper abdominal pain was observed in 5 cases, right upper abdominal mass in 1 case, asthenia and anorexia1 in 1 case, and the remaining 3 cases were found with tumor when receiving routine physical examination. For imaging finding, 8 cases were diagnosed as isolated liver mass, and 2 were found with multiple masses in the liver. All of the 10 patients were confirmed by pathological examination, of which 3 were diagnosed by biopsy before operation, and 7 were confirmed with pathology after operation. 6 cases underwent radical resection, 1 case received microwave ablation, 1 underwent liver resection and intravenous chemotherapy pump implantation, 1 received chemotherapy alone and 1 abandoned treatment. To the submission date of this article, 6 cases survived without recurrence, 1 case suffered recurrence 1 month after operation with multiple lymph node metastases in the peritoneum and remained alive. 2 cases died, 1 of which died of no treatment after biopsy, 1 died of multiple distant metastases after 1 period of chemotherapy, and 1 lost follow-up.

Conclusions

There is no specific clinical manifestations of hepatic NEN. It should be confirmed by pathological examination. Surgical resection is the first choice for treatment. For patients with unresectable mass, TACE, microwave ablation and chemotherapy can be applied.

表1 10例原发性肝脏神经内分泌肿瘤患者临床资料
图1 一例原发性肝脏神经内分泌肿瘤患者腹部CT检查图
图2 一例原发性肝脏NEN患者肿瘤组织切片免疫组化染色图
[1]
Fenoglio LM, Severini S, Ferrigno D, et al. Primary hepatic carcinoid: a case report and literature review[J]. World J Gastroenterol,2009, 15(19):2418-2422.
[2]
Edmondson HA, National Research Council, Subcommittee on Oncology. Tumors of the liver and intrahepatic bile ducts (atlas of tumor pathology)[M].Washington: Armed Forces Institute of Pathology,1958.
[3]
Park CH, Chung JW, Jang SJ, et al. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas[J]. J Gastroenterol Hepatol, 2012,27(8):1306-1311.
[4]
Wang LM, An SL, Wu JX. Diagnosis and therapy of primary hepatic neuroendocrine carcinoma: clinical analysis of 10 cases[J]. Asian Pac J Cancer Prev, 2014, 15(6):2541-2546.
[5]
Lambrescu IM, Martin S, Cima L, et al. Primary hepatic neuroendocrine tumor after 4 years tumor-free follow-up[J]. J Gastrointestin Liver Dis, 2015, 24(2): 241-244.
[6]
Sotiropoulos GC, Charalampoudis P, Delladetsima I, et al. Surgery for giant primary neuroendocrine carcinoma of the liver[J].J Gastrointest Surg, 2014, 18(4): 839-841.
[7]
Bosman F, Carneiro F. World Health Organization classification of tumours, pathology and genetics of tumours of the digestive system[M]. Lyon: IARC Press, 2010.
[8]
Knox CD, Anderson CD, Lamps LW, et al. Long-term survival after resection for primary hepatic carcinoid tumor[J]. Ann Surg Oncol, 2003, 10(10):1171-1175.
[9]
朱雄增.胃肠胰神经内分泌肿瘤新分类的临床意义[J].中华胃肠外科杂志,2013,16(1):12-14.
[10]
Vinik AI, Chaya C. Clinical presentation and diagnosis of neuroendocrine tumors[J]. Hematol Oncol Clin North Am, 2016, 30(1):21-48.
[11]
Fraenkel M, Faggiano A, Valk GD. Epidemiology of neuroendocrine tumors[J]. Front Horm Res, 2015(44):1-23.
[12]
Camargo ÉS, Viveiros Mde M, Corrêa Neto IJ, et al. Primary hepatic carcinoid tumor: case report and literature review[J]. Einstein, 2014, 12(4):505-508.
[13]
Jia C, Zhang Y, Xu J, et al. Experience in primary hepatic neuroendocrine tumor[J]. Turk J Gastroenterol, 2012, 23 (5):546-551.
[14]
Quartey B. Primary hepatic neuroendocrine tumor: what do we know now? [J]. World J Oncol, 2011, 2(5):209-216.
[15]
Hallet J, Law CH, Cukier M, et al. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes[J]. Cancer, 2015, 121(4): 589-597.
[16]
Lin CW, Lai CH, Hsu CC, et al. Primary hepatic carcinoid tumor: a case report and review of the literature[J]. Cases J, 2009, 2(1):90.
[17]
张文书,赵婧,纪元,等.肝原发性与转移性神经内分泌肿瘤的临床病理分析[J].中华肝胆外科杂志,2012,18(3):161-165.
[18]
Pilichowska M, Kimura N, Ouchi A, et al. Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases[J]. Pathol Int, 1999, 49(4):318-324.
[19]
Kellock T, Tuong B, Harris AC, et al. Diagnostic imaging of primary hepatic neuroendocrine tumors: a case and discussion of the literature[J]. Case Rep Radiol, 2014:156491.
[20]
Dala R, Shoosmith J, Lilenbaum R, et al. Primary hepatic neuroendocrine carcinoma: an underdiagnosed entity[J]. Ann Diagn Pathol, 2006, 10(1):28-31.
[21]
Hwang S, Lee YJ, Lee SG, et al. Surgical treatment of primary neuroendocrine tumors of the liver[J]. J Gastrointest Surg, 2008, 12(4):725-730.
[22]
Skagias L, Vasou O, Ntinis A, et al. Primary hepatic neuroendocrine tumor with exophytic growth: report of a case with diagnosis by fine needle aspiration biopsy[J]. Acta Cytol, 2010, 54(2):202-204.
[23]
Yalav O, Ülkü A, Akçam TA, et al. Primary hepatic neuroendocrine tumor: five cases with different preoperative diagnoses[J]. Turk J Gastroenterol, 2012, 23(3):272-278.
[24]
Iwao M, Nakamuta M, Enjoji M, et al. Primary hepatic carcinoid tumor: case report and review of 53 cases[J]. Med Sci Monit, 2001, 7(4):746-750.
[25]
Taner T, Atwell TD, Zhang L, et al. Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection[J]. HPB, 2013, 15(3):190-195.
[26]
Wängberg B, Nilsson O, Johanson V, et al. Somatostatin receptors in the diagnosis and therapy of neuroendocrine tumor[J]. Oncologist, 1997, 2(1):50-58.
[27]
Alagusundaramoorthy SS, Gedaly R. Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor[J]. World J Gastroenterol, 2014, 20(39):14348-14358.
[28]
Mazzaferro V, Pulvirenti A, Coppa J. Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?[J].J Hepatol, 2007, 47(4):460-466.
[29]
Olausson M, Friman S, Herlenius G, et al. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors[J]. Liver Transpl, 2007, 13(3):327-333.
[30]
Gedaly R, Daily MF, Davenport D, et al. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database[J]. Arch Surg, 2011, 146 (8):953-958.
[1] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[2] 钟锴, 蒋铁民, 张瑞青, 吐尔干艾力·阿吉, 邵英梅, 郭强. 加速康复外科在肝囊型棘球蚴病肝切除术中的应用分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 425-429.
[3] 朴成林, 蓝炘, 司振铎, 李强, 冯健, 安峰铎, 冷建军. 胰十二指肠切除联合肝切除术疗效分析:附5例报告(附视频)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 363-367.
[4] 冷建军, 朴成林, 司振铎. 胰十二指肠切除术联合小范围肝切除、血管切除重建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 384-384.
[5] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[6] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[7] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[8] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[9] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[10] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[11] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[12] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[13] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[14] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[15] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?